This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Samsung Life Public Welfare Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: The Innovations of Jun Young Choi
Introduction
Jun Young Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods for inhibiting kinases. His work is characterized by a focus on the therapeutic applications of chemical compounds.
Latest Patents
One of Jun Young Choi's key patents is titled "Method of inhibiting kinase by mesylate salts of triazolopyrazine derivatives." This patent discloses a mesylate salt of methanesulfonic acid and a triazolopyrazine derivative, along with pharmaceutical compositions, methods of making the salt, and its therapeutic uses. This innovation highlights his commitment to advancing medical science through novel chemical solutions. He holds 1 patent.
Career Highlights
Jun Young Choi is currently associated with the Samsung Life Public Welfare Foundation. His role at this organization allows him to contribute to both scientific research and public welfare initiatives. His work is instrumental in bridging the gap between innovative research and practical applications in healthcare.
Collaborations
He has collaborated with talented individuals such as Na Young Kim and Kyung-eui Park. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that encourages innovation.
Conclusion
Jun Young Choi exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in kinase inhibition, reflect a dedication to improving health outcomes through scientific advancement. His work continues to inspire future research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile